Osteal Therapeutics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$15.6M
- Investors
-
9
Osteal Therapeutics General Information
Description
Developer of infection therapeutics designed to reduce the mortality, morbidity, and cost of care associated with musculoskeletal infections. The company's therapeutics offers a drug and device combination product to treat orthopedic infections, infected joint prosthesis, and their consequences, and provide a fast and reliable treatment option, enabling orthopedic surgeons to offer an effective treatment for musculoskeletal diseases.
Contact Information
Website
www.ostealtx.comCorporate Office
- 4835 Lyndon B. Johnson Freeway
- Suite 635
- Dallas, TX 75244
- United States
Corporate Office
- 4835 Lyndon B. Johnson Freeway
- Suite 635
- Dallas, TX 75244
- United States
Osteal Therapeutics Timeline
Osteal Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series E) | 05-Nov-2025 | $15.6M | Completed | Clinical Trials - Phase 2 | ||
| 5. Later Stage VC (Series D) | 22-May-2024 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC (Series C) | 11-Sep-2023 | Completed | Clinical Trials - Phase 2 | |||
| 3. Debt - General | 28-Jun-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series B) | 17-Dec-2021 | $30.2M | $37.7M | Completed | Clinical Trials - Phase 2 | |
| 1. Later Stage VC (Series A) | 18-Apr-2018 | $7.41M | $7.41M | Completed | Clinical Trials - General |
Osteal Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 11,250,481 | $0.000100 | $2.9 | $2.9 | 1x | $2.9 | 27.83% | |
| Series A | 4,335,995 | $0.000100 | $1.79 | $1.79 | 1x | $1.79 | 10.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Osteal Therapeutics Comparisons
Industry
Financing
Details
Osteal Therapeutics Competitors (3)
One of Osteal Therapeutics’s 3 competitors is Causeway Therapeutics, a Venture Capital-Backed company based in Glasgow, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Causeway Therapeutics | Venture Capital-Backed | Glasgow, United Kingdom | ||||
| Cybrexa Therapeutics | Venture Capital-Backed | New Haven, CT | ||||
| Vir Biotechnology | Formerly VC-backed | San Francisco, CA |
Osteal Therapeutics Patents
Osteal Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026044016-A1 | Irrigation system and methods of use | Pending | 21-Aug-2024 | ||
| WO-2026039544-A1 | Methods of treating a localized infection with locally administered antibiotics | Pending | 14-Aug-2024 | ||
| AU-2024225462-A1 | Irrigation system and methods of use | Pending | 21-Feb-2023 | ||
| EP-4669386-A1 | Irrigation system and methods of use | Pending | 21-Feb-2023 | ||
| US-12521484-B2 | Irrigation system and methods of use | Active | 21-Feb-2023 | A61M5/16809 |
Osteal Therapeutics Signals
Osteal Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HM Venture Partners | Venture Capital | Minority | ||
| Zimmer Biomet Holdings | Corporation | Minority | ||
| Asteroid Partners | Venture Capital | Minority | ||
| Gideon Strategic Partners | Limited Partner | Minority | ||
| GOS Capital | Venture Capital | Minority |
Osteal Therapeutics FAQs
-
When was Osteal Therapeutics founded?
Osteal Therapeutics was founded in 2013.
-
Where is Osteal Therapeutics headquartered?
Osteal Therapeutics is headquartered in Dallas, TX.
-
What is the size of Osteal Therapeutics?
Osteal Therapeutics has 49 total employees.
-
What industry is Osteal Therapeutics in?
Osteal Therapeutics’s primary industry is Drug Discovery.
-
Is Osteal Therapeutics a private or public company?
Osteal Therapeutics is a Private company.
-
What is the current valuation of Osteal Therapeutics?
The current valuation of Osteal Therapeutics is .
-
What is Osteal Therapeutics’s current revenue?
The current revenue for Osteal Therapeutics is .
-
How much funding has Osteal Therapeutics raised over time?
Osteal Therapeutics has raised $133M.
-
Who are Osteal Therapeutics’s investors?
HM Venture Partners, Zimmer Biomet Holdings, Asteroid Partners, Gideon Strategic Partners, and GOS Capital are 5 of 9 investors who have invested in Osteal Therapeutics.
-
Who are Osteal Therapeutics’s competitors?
Causeway Therapeutics, Cybrexa Therapeutics, and Vir Biotechnology are competitors of Osteal Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process